2.5 mg semaglutide equivalent to tirzepatide as Compared with for the Treatment of Obesity Switching from Semaglutide to Tirzepatide:

Roche indicated that patients seeking maximum weight loss might choose more potent therapies like its experimental dual-acting enicepatide, while others might prefer more modest weight loss with fewer side effects for easier long-term adherence

A lyophilized peptide is a freeze-dried research material prepared to support laboratory stability, storage, and controlled research preparation

SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction

Semaglutide, by contrast, shows significant deceleration after 6-8 months, with monthly weight loss dropping to 1-2 pounds as patients approach the 12-15% plateau

Was it stimulation

Ask your healthcare provider about your dose